Skip to main content
PureTech Health plc logo

PureTech Health plc — Investor Relations & Filings

Ticker · PRTC ISIN · GB00BPVG5C82 LEI · 213800LVPDNO2Z9T9I39 IL Manufacturing
Open in API
Filings indexed 1,319 across all filing types
Latest filing 2024-06-07 Major Shareholding Noti…
Country GB United Kingdom
Listing IL PRTC

About PureTech Health plc

https://puretechhealth.com/

PureTech Health is a clinical-stage biotherapeutics company dedicated to discovering, developing, and commercializing new classes of medicine for devastating diseases. The company's research and development engine focuses on advancing novel treatments by enhancing on-target efficacy, improving tolerability, or enabling oral administration of therapeutics with validated mechanisms. Its pipeline includes wholly-owned therapeutic candidates targeting a range of conditions, including idiopathic pulmonary fibrosis, neuropsychiatric disorders, and various cancers.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly labeled with "RNS Number : 6823R" and contains a standard form for notification of major holdings, specifically "TR-1: Standard form for notification of major holdings." This form details changes in voting rights held by a shareholder (Invesco Ltd.) in the issuer (PureTech Health PLC). This type of filing, which reports changes in significant share ownership crossing notification thresholds, corresponds directly to the Major Shareholding Notification category. Although it is distributed via RNS, the specific content dictates the classification over the general RNS fallback. It is not an Earnings Release (ER), Annual Report (10-K), or Director's Dealing (DIRS), but a notification of a major shareholder's position change.
2024-06-07 English
FORM 6-K
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a Form 6-K, which is a report of a foreign private issuer filed with the SEC. It references a press release titled 'PureTech Health plc Result of General Meeting' dated June 6, 2024, which is furnished as an exhibit. The document itself is short (1683 characters) and primarily serves to announce the press release related to the result of a general meeting. There is no detailed financial data or comprehensive report content. According to the 'Menu vs Meal' rule, this is an announcement of a report (press release) rather than the report itself. The content relates to the result of a general meeting, which aligns with Declaration of Voting Results & Voting Rights Announcements (DVA). Therefore, the appropriate classification is DVA with high confidence.
2024-06-06 English
Result of Meeting
AGM Information Classification · 99% confidence The document is an official announcement released via RNS (RNS Number: 3148R) on June 6, 2024. The primary content details the 'Result of General Meeting,' specifically reporting the outcome of a poll on a Special Resolution related to a tender offer. This directly corresponds to the reporting of official results from a shareholder vote at a general meeting. Therefore, the most appropriate classification is Declaration of Voting Results & Voting Rights Announcements (DVA). It is not a general regulatory filing (RNS) because it is highly specific, nor is it an AGM presentation (AGM-R), but rather the formal results announcement following the meeting.
2024-06-06 English
SC TO-I/A Filing
Regulatory Filings
2024-06-06 English
FORM 6-K
Merger & Acquisition Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, PureTech Health plc, with the SEC. It contains a press release about a proposed $100 million tender offer. The document is short (1752 characters) and primarily serves to furnish a press release rather than detailed financial data or a full report. The content relates to a tender offer, which is a type of merger/acquisition activity. Therefore, the document should be classified under Merger & Acquisition (MA) filings, as it announces a tender offer amendment. The document is not a full report but an announcement of a transaction-related event.
2024-06-04 English
Merger & Acquisition 2024
Merger & Acquisition Classification · 95% confidence The document is a letter from legal counsel responding to comments from the SEC staff regarding a Schedule TO-I filing dated May 20, 2024. The Schedule TO is a tender offer statement filed under SEC regulations related to mergers and acquisitions. The letter addresses specific SEC comments and amendments to the Schedule TO filing. There is no financial data or report content here, but rather a regulatory correspondence related to a tender offer filing. This fits the category of Merger & Acquisition filings, specifically related to tender offer communications. Therefore, the appropriate classification is 'MA' (Merger & Acquisition). The document length and content confirm it is not a brief announcement or certification but a substantive regulatory filing response.
2024-06-04 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.